wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38991958-8CE2CC58-E8F3-4877-A96B-F2A63A82F9DA
Q38991958-8CE2CC58-E8F3-4877-A96B-F2A63A82F9DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38991958-8CE2CC58-E8F3-4877-A96B-F2A63A82F9DA
Osimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experience.
P2860
Q38991958-8CE2CC58-E8F3-4877-A96B-F2A63A82F9DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38991958-8CE2CC58-E8F3-4877-A96B-F2A63A82F9DA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ddcd0adaead05c41e3b436ec6900e6e93a0681f7
P2860
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.